ReviewBiomedicines2023

Effect of Glucagon-like Peptide-1 Receptor Agonists on Cardio-Metabolic Risk Factors among Obese/Overweight Individuals Treated with Antipsychotic Drug Classes: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Dimitrios Patoulias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.